For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Genpact Ltd’s stock clocked out at $46.22, down -2.57% from its previous closing price of $47.44. In other words, the price has decreased by -$2.57 from its previous closing price. On the day, 1.22 million shares were traded. G stock price reached its highest trading level at $47.51 during the session, while it also had its lowest trading level at $46.18.
Ratios:
To gain a deeper understanding of G’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.76 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.28. For the most recent quarter (mrq), Quick Ratio is recorded 1.51 and its Current Ratio is at 1.51. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.39.
Upgrades & Downgrades
In the most recent recommendation for this company, Susquehanna on December 12, 2025, initiated with a Neutral rating and assigned the stock a target price of $50.
On October 23, 2025, Citigroup started tracking the stock assigning a Neutral rating and target price of $43.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 13 ’26 when Dewan Sameer sold 15,088 shares for $46.65 per share. The transaction valued at 703,855 led to the insider holds 37,749 shares of the business.
Vashisht Riju sold 16,016 shares of G for $747,146 on Jan 13 ’26. The Senior Vice President now owns 95,521 shares after completing the transaction at $46.65 per share. On Jan 13 ’26, another insider, HEATHER D WHITE, who serves as the Officer of the company, bought 10,740 shares for $46.64 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, G now has a Market Capitalization of 8054763520 and an Enterprise Value of 8653106176. As of this moment, Genpact’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.90, and their Forward P/E ratio for the next fiscal year is 11.70. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.12. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.59 while its Price-to-Book (P/B) ratio in mrq is 3.13. Its current Enterprise Value per Revenue stands at 1.727 whereas that against EBITDA is 10.28.
Stock Price History:
The Beta on a monthly basis for G is 0.74, which has changed by 0.051651478 over the last 52 weeks, in comparison to a change of 0.15507638 over the same period for the S&P500. Over the past 52 weeks, G has reached a high of $56.76, while it has fallen to a 52-week low of $37.49. The 50-Day Moving Average of the stock is 1.17%, while the 200-Day Moving Average is calculated to be 4.34%.
Shares Statistics:
It appears that G traded 1.84M shares on average per day over the past three months and 1265070 shares per day over the past ten days. A total of 172.41M shares are outstanding, with a floating share count of 157.64M. Insiders hold about 8.57% of the company’s shares, while institutions hold 96.46% stake in the company. Shares short for G as of 1767139200 were 6504779 with a Short Ratio of 3.54, compared to 1764288000 on 7141439. Therefore, it implies a Short% of Shares Outstanding of 6504779 and a Short% of Float of 4.31.
Dividends & Splits
With its trailing 12-month dividend rate of 0.663, G has a forward annual dividend rate of 0.68. Against a Trailing Annual Dividend Yield of 0.013975549. The stock’s 5-year Average Dividend Yield is 1.25.
Earnings Estimates
The firm’s stock currently is rated by 11.0 analysts. The consensus estimate for the next quarter is $0.91, with high estimates of $0.97 and low estimates of $0.89.
Analysts are recommending an EPS of between $3.64 and $3.6 for the fiscal current year, implying an average EPS of $3.62. EPS for the following year is $3.95, with 12.0 analysts recommending between $4.07 and $3.88.
Revenue Estimates
In. The current quarter, 10 analysts expect revenue to total $1.31B. It ranges from a high estimate of $1.32B to a low estimate of $1.3B. As of. The current estimate, Genpact Ltd’s year-ago sales were $1.25BFor the next quarter, 10 analysts are estimating revenue of $1.29B. There is a high estimate of $1.32B for the next quarter, whereas the lowest estimate is $1.27B.
A total of 12 analysts have provided revenue estimates for G’s current fiscal year. The highest revenue estimate was $5.08B, while the lowest revenue estimate was $5.07B, resulting in an average revenue estimate of $5.07B. In the same quarter a year ago, actual revenue was $4.77BBased on 12 analysts’ estimates, the company’s revenue will be $5.42B in the next fiscal year. The high estimate is $5.48B and the low estimate is $5.37B.
